glp 1 and glp 2 drugs GLP-1 are all approved for glucose control in type diabetes (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, obesity. None glp 1 equivalency chart Promising

2017;26(2):343352.e2

Research thus far shows strong benefits for weight loss and blood sugar control similar to injectable GLP-1s, such as semaglutide and tirzepatide

Tirzepatide users were less likely to experience any major cardiovascular problems following surgery than people not on the drug (roughly 30% lower risk), though the rate of some problems like heart attacks remained roughly the same between the two groups

STEP 1 for Effective Weight Control Another First Step

Acknowledgements This work was supported by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre